Effects of Post-Myocardial Infarction Heart Failure on the Bone Vascular Niche
J. Hoffmann, G. Luxan, W. T. Abplanalp, S.-F. Glaser, T. Rasper, A. Fischer, M. Muhly-Reinholz, D. John, B. Assmus, A. M. Zeiher, S. Dimmeler
Abstract
Bone vasculature provides protection and signals necessary to control stem cell quiescence and renewal1. Specifically, type H capillaries, which highly express Endomucin, constitute the endothelial niche supporting a microenvironment of osteoprogenitors and long-term hematopoietic stem cells2-4. The age-dependent decline in type H endothelial cells was shown to be associated with bone dysregulation and accumulation of hematopoietic stem cells, which display cell-intrinsic alterations and reduced functionality3. The regulation of bone vasculature by chronic diseases, such as heart failure is unknown. Here, we describe the effects of myocardial infarction and post-infarction heart failure on the vascular bone cell composition. We demonstrate an age-independent loss of type H bone endothelium in heart failure after myocardial infarction in both mice and in humans. Using single-cell RNA sequencing, we delineate the transcriptional heterogeneity of human bone marrow endothelium showing increased expression of inflammatory genes, including IL1B and MYC, in ischemic heart failure. Inhibition of NLRP3-dependent IL-1{beta} production partially prevents the post-myocardial infarction loss of type H vasculature in mice. These results provide a rationale for using anti-inflammatory therapies to prevent or reverse the deterioration of vascular bone function in ischemic heart disease.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bone marrow mesenchymal stromal cells mediate cellular inflammation in HFpEF
Kyle I. Mentkowski, I‐Hsiu Lee, … Matthias Nahrendorf·bioRxiv·Mar 28, 2025
- Myeloid Cell-Derived IL1β Contributes to Pulmonary Vascular Remodeling in Heart Failure with Preserved Ejection Fraction
V. Agrawal, J. A. Kropski, … A. R. Hemnes·bioRxiv·May 18, 2023
- A single dose of intravenous human amniotic membrane-derived mesenchymal stem cells limits transmural infarction, reduces fibrosis size, and improves left ventricular systolic function in the myocardial ischemic/reperfusion model of rats
J.-W. Sung, Y.-T. Yeh, … S.-C. Wu·bioRxiv·Jul 30, 2022
- Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
J. M. Amrute, X. Luo, … K. Lavine·bioRxiv·Oct 17, 2022
- Splenic follicular B cells promote adverse cardiac remodeling after myocardial infarction via MHC II-dependent antigen presentation.
Obialunanma V. Ebenebe, Jana P. Lovell, … Luigi Adamo·bioRxiv·May 8, 2024
- A Novel ARNT-Dependent HIF-2α Signaling as a Protective Mechanism for Cardiac Microvascular Barrier Integrity and Heart Function Post-Myocardial Infarction